Markus Renschler MD - 21 Dec 2022 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Role
President and CEO, Director
Signature
/s/ Adam M. Veness, as attorney-in-fact for Markus Renschler, M.D.
Issuer symbol
N/A
Transactions as of
21 Dec 2022
Net transactions value
+$146,060
Form type
4
Filing time
23 Dec 2022, 15:47:30 UTC
Previous filing
24 Feb 2022
Next filing
07 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Options Exercise $109,535 +106,345 +13% $1.03 948,299 21 Dec 2022 Direct F1
transaction CYT Common Stock Options Exercise $36,524 +30,437 +3.2% $1.20 978,736 21 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to Buy) Options Exercise $0 -106,345 -100% $0.000000* 0 21 Dec 2022 Common Stock 106,345 $1.03 Direct F1, F2
transaction CYT Stock Option (Right to Buy) Options Exercise $0 -30,437 -48% $0.000000 32,973 21 Dec 2022 Common Stock 30,437 $1.20 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Due to rounding in connection with the Issuer's reverse stock split during its initial public offering, the exercise price and the number of securities underlying this option were immaterially incorrect as reported on the Reporting Person's Form 3 filing on June 17, 2021. These numbers have been corrected in this Form 4.
F2 The option vested at a rate of 18,334 shares per month at the end of each successive one-month period beginning January 3, 2019, for 40 months, and at a rate of 14,703 shares per month at the end of the 41st month, at which point the option was fully vested.
F3 The option vests as to 1/48th of the underlying shares of common stock on February 1, 2020, and at the same rate at the end of each successive one-month period following such date until the fourth anniversary of such date, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney